Stocktoria
IRONWOOD PHARMACEUTICALS INC IRWD
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2010-02-03
IRONWOOD PHARMACEUTICALS INC statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | 33.3% | 26.5% | -213.5% | 61.0% | 56.1% |
| Net margin | 8.1% | 0.3% | -226.4% | 42.6% | 127.7% |
| FCF margin | 42.9% | 29.4% | 41.4% | 66.6% | 63.2% |
| Return on assets | 6.1% | 0.3% | -212.8% | 15.9% | 46.9% |
| Return on equity | -9.2% | -0.3% | 289.4% | 26.8% | 87.2% |
| Debt / equity | — | -0.66× | -1.15× | 0.61× | 0.75× |
| Current ratio | 1.13 | 4.69 | 0.84 | 30.58 | 4.61 |
| Revenue growth | -15.7% | -20.6% | 7.8% | -0.8% | 6.2% |
Source: SEC EDGAR filings · CIK 0001446847 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.